Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Suzan J. G. Knottnerus(Amsterdam UMC Location University of Amsterdam), Riekelt H. Houtkooper(Amsterdam University Medical Centers), Frits A. Wijburg(Emma Kinderziekenhuis), Rob C. I. Wüst(Amsterdam Neuroscience), Jeannette C. Bleeker(Amsterdam UMC Location University of Amsterdam), Gepke Visser(Amsterdam UMC Location University of Amsterdam), Sacha Ferdinandusse(Amsterdam UMC Location University of Amsterdam), Lodewijk IJlst(Amsterdam UMC Location University of Amsterdam), Ronald J. A. Wanders(Amsterdam University Medical Centers)
Cited by 330
Related Papers
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
|Endocrine Reviews|2010|879
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
|Endocrine Reviews|2018|735
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713